SRPT Stock Summary

• With a price/sales ratio of 19.59, Sarepta Therapeutics Inc has a higher such ratio than 94.55% of stocks in our set.
• Over the past twelve months, SRPT has reported earnings growth of 175.18%, putting it ahead of 92.92% of US stocks in our set.
• As for revenue growth, note that SRPT's revenue has grown 42.76% over the past 12 months; that beats the revenue growth of 87.7% of US companies in our set.
• Stocks that are quantitatively similar to SRPT, based on their financial statements, market capitalization, and price volatility, are PTCT, RTRX, NEU, SPPI, and XXII.
• SRPT's SEC filings can be seen here. And to visit Sarepta Therapeutics Inc's official web site, go to www.sarepta.com.